• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤中癌症干细胞出现频率不同的一种可能解释。

A possible explanation for the variable frequencies of cancer stem cells in tumors.

机构信息

Departamento de Física, Instituto de Ciências Exatas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brasil.

出版信息

PLoS One. 2013 Aug 7;8(8):e69131. doi: 10.1371/journal.pone.0069131. eCollection 2013.

DOI:10.1371/journal.pone.0069131
PMID:23950884
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3737222/
Abstract

A controversy surrounds the frequency of cancer stem cells (CSCs) in solid tumors. Initial studies indicated that these cells had a frequency ranging from 0.0001 to 0.1% of the total cells. Recent studies have shown that this does not always seem to be the case. Some of these studies have indicated a frequency of [Formula: see text]. In this paper we propose a stochastic model that is able to capture this potential variability in the frequency of CSCs among the various type of tumors. Considerations regarding the heterogeneity of the tumor cells and its consequences are included. Possible effects on conventional treatments in clinical practice are also described. The model results suggest that traditional attempts to combat cancer cells with rapid cycling can be very stimulating for the cancer stem cell populations.

摘要

癌症干细胞(CSC)在实体瘤中的频率存在争议。最初的研究表明,这些细胞在总细胞中的频率范围为 0.0001 到 0.1%。最近的研究表明,情况并非总是如此。其中一些研究表明频率为[公式:见正文]。在本文中,我们提出了一个随机模型,能够捕捉到各种类型肿瘤中 CSC 频率的这种潜在可变性。还考虑了肿瘤细胞的异质性及其后果。还描述了对临床实践中常规治疗的可能影响。模型结果表明,用快速循环的癌细胞来对抗癌症的传统尝试可能会对癌症干细胞群体产生非常大的刺激。

相似文献

1
A possible explanation for the variable frequencies of cancer stem cells in tumors.肿瘤中癌症干细胞出现频率不同的一种可能解释。
PLoS One. 2013 Aug 7;8(8):e69131. doi: 10.1371/journal.pone.0069131. eCollection 2013.
2
Strategies for cancer stem cell elimination: insights from mathematical modeling.癌症干细胞消除策略:数学建模的启示。
J Theor Biol. 2012 Apr 7;298:32-41. doi: 10.1016/j.jtbi.2011.12.016. Epub 2011 Dec 23.
3
The noise and the KISS in the cancer stem cells niche.肿瘤干细胞生态位中的噪声和 KISS。
J Theor Biol. 2013 Oct 21;335:79-87. doi: 10.1016/j.jtbi.2013.06.025. Epub 2013 Jul 1.
4
Non-stem cancer cell kinetics modulate solid tumor progression.非干细胞癌细胞动力学调节实体瘤进展。
Theor Biol Med Model. 2011 Dec 30;8:48. doi: 10.1186/1742-4682-8-48.
5
Stochastic dynamics of hematopoietic tumor stem cells.造血肿瘤干细胞的随机动力学
Cell Cycle. 2007 Feb 15;6(4):461-6. doi: 10.4161/cc.6.4.3853. Epub 2007 Feb 17.
6
A Bayesian statistical analysis of stochastic phenotypic plasticity model of cancer cells.基于贝叶斯统计的癌细胞随机表型可塑性模型分析。
J Theor Biol. 2018 Oct 7;454:70-79. doi: 10.1016/j.jtbi.2018.05.031. Epub 2018 May 29.
7
Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.新型二萜化合物 ovatodiolide 通过抑制 Wnt/β-catenin 信号通路下调肝癌干细胞干性抑制肝癌干细胞样特性。
Am J Chin Med. 2018;46(4):891-910. doi: 10.1142/S0192415X18500477. Epub 2018 May 24.
8
Cancer stem cells: lessons from leukemia.癌症干细胞:白血病的启示
Trends Cell Biol. 2005 Sep;15(9):494-501. doi: 10.1016/j.tcb.2005.07.004.
9
On the proportion of cancer stem cells in a tumour.肿瘤中癌症干细胞的比例。
J Theor Biol. 2010 Oct 21;266(4):708-11. doi: 10.1016/j.jtbi.2010.07.031. Epub 2010 Aug 3.
10
Are cancer stem cells the sole source of tumor?癌症干细胞是肿瘤的唯一来源吗?
J Huazhong Univ Sci Technolog Med Sci. 2014 Oct;34(5):621-625. doi: 10.1007/s11596-014-1327-8. Epub 2014 Oct 16.

引用本文的文献

1
Heterogeneous protein dynamics links to mitochondrial activity, glucose transporter, and ALDH cancer stem cell properties.异质性蛋白质动力学与线粒体活性、葡萄糖转运蛋白及醛脱氢酶癌症干细胞特性相关。
BMC Cancer. 2025 Jul 1;25(1):1085. doi: 10.1186/s12885-025-14460-x.
2
Head and neck cancer management and cancer stem cells implication.头颈癌的治疗与癌症干细胞的影响
Saudi Dent J. 2019 Oct;31(4):395-416. doi: 10.1016/j.sdentj.2019.05.010. Epub 2019 Jun 10.
3
The invasion of de-differentiating cancer cells into hierarchical tissues.

本文引用的文献

1
Implication of cancer stem cells in cancer drug development and drug delivery.癌症干细胞在癌症药物研发与药物递送中的意义。
J Lab Autom. 2013 Feb;18(1):6-11. doi: 10.1177/2211068212454739. Epub 2012 Aug 14.
2
A restricted cell population propagates glioblastoma growth after chemotherapy.化疗后,受限制的细胞群体促进胶质母细胞瘤生长。
Nature. 2012 Aug 23;488(7412):522-6. doi: 10.1038/nature11287.
3
Defining the mode of tumour growth by clonal analysis.通过克隆分析定义肿瘤生长方式。
去分化癌细胞侵入层次组织。
PLoS Comput Biol. 2019 Jul 1;15(7):e1007167. doi: 10.1371/journal.pcbi.1007167. eCollection 2019 Jul.
4
Epigenetic control of variation and stochasticity in metabolic disease.代谢疾病中变异和随机性的表观遗传控制。
Mol Metab. 2018 Aug;14:26-38. doi: 10.1016/j.molmet.2018.05.010. Epub 2018 May 18.
5
Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness.p53的新兴非经典功能与调控:p53与干性
Int J Mol Sci. 2016 Nov 26;17(12):1982. doi: 10.3390/ijms17121982.
6
A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?对癌症干细胞标志物的新见解:结直肠癌中局部和循环癌症干细胞标志物是否相关?
Tumour Biol. 2016 Feb;37(2):2405-14. doi: 10.1007/s13277-015-3989-7. Epub 2015 Sep 17.
7
Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.在接受放化疗的结直肠癌患者中,循环癌干细胞标志物DCLK1而非Lgr5上调。
Tumour Biol. 2015 Jun;36(6):4801-10. doi: 10.1007/s13277-015-3132-9. Epub 2015 Jan 29.
Nature. 2012 Aug 23;488(7412):527-30. doi: 10.1038/nature11344.
4
Do cancer cells undergo phenotypic switching? The case for imperfect cancer stem cell markers.癌细胞是否会经历表型转换?不完全的癌症干细胞标志物案例。
Sci Rep. 2012;2:441. doi: 10.1038/srep00441. Epub 2012 Jun 7.
5
Tumor heterogeneity and its implication for drug delivery.肿瘤异质性及其对药物传递的影响。
J Control Release. 2012 Dec 10;164(2):187-91. doi: 10.1016/j.jconrel.2012.04.014. Epub 2012 Apr 15.
6
Intra-tumour heterogeneity: a looking glass for cancer?肿瘤内异质性:癌症的哈哈镜?
Nat Rev Cancer. 2012 Apr 19;12(5):323-34. doi: 10.1038/nrc3261.
7
What does the concept of the stem cell niche really mean today?如今,干细胞微环境的概念究竟意味着什么?
BMC Biol. 2012 Mar 9;10:19. doi: 10.1186/1741-7007-10-19.
8
Model for in vivo progression of tumors based on co-evolving cell population and vasculature.基于细胞群体和脉管系统共同进化的肿瘤体内进展模型。
Sci Rep. 2011;1:31. doi: 10.1038/srep00031. Epub 2011 Jul 6.
9
Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer.干细胞可塑性的调控:机制及其与组织生物学和癌症的相关性。
Mol Ther. 2012 May;20(5):887-97. doi: 10.1038/mt.2012.2. Epub 2012 Feb 7.
10
A quantitative theory of solid tumor growth, metabolic rate and vascularization.实体瘤生长、代谢率和血管生成的定量理论。
PLoS One. 2011;6(9):e22973. doi: 10.1371/journal.pone.0022973. Epub 2011 Sep 29.